Patents by Inventor Andreas Kammer

Andreas Kammer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multiepitope vaccine for Her2/neu-associated cancers
    Patent number: 8852604
    Abstract: The present invention includes fusion peptides comprising fragments of the cancer-related protein Her2/neu, methods of preparing such fusion peptides, virosomes comprising such fusion peptides, and uses of such fusion peptides or virosomes for the prevention, treatment or amelioration of a cancer characterized by expression or over-expression of the Her2/neu protein.
    Type: Grant
    Filed: August 18, 2010
    Date of Patent: October 7, 2014
    Assignee: Pevion Biotech AG
    Inventors: Andreas Kammer, Mario Amacker, Rinaldo Zurbriggen
  • Trans-adjuvant system
    Patent number: 8496962
    Abstract: The present invention relates to a novel adjuvant system that generates an efficient immune response against antigens of various origins while reducing the risk of toxic side effects attendant to the use of known adjuvants. The novel adjuvant of the present invention comprises virosomes and allows antigenic molecules to be bound to or encapsulated in a variety of delivery vehicles which are easier to prepare for virosomes.
    Type: Grant
    Filed: December 15, 2006
    Date of Patent: July 30, 2013
    Assignee: Pevion Biotech, Ltd.
    Inventors: Rinaldo Zurbriggen, Andreas Kammer
  • Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
    Patent number: 8367077
    Abstract: The present invention relates to virosomes comprising hemagglutinin (HA) with improved fusion activity. Preferably, the HA comprised in said virosomes was derived from influenza virus produced in a cell line. The present invention also relates to compositions and a kit comprising the virosomes according to the invention. Further, the present invention relates to uses and methods involving said virosomes, as well as to a method for preparing same.
    Type: Grant
    Filed: June 13, 2008
    Date of Patent: February 5, 2013
    Assignee: Pevion Biotech, AG
    Inventors: Rinaldo Zurbriggen, Christian Moser, Andreas Kammer, Mario Amacker, Nicole Westerfeld, Silvia Rasi
  • Multiepitope Vaccine for Her2/Neu-Associated Cancers
    Publication number: 20120195962
    Abstract: The present invention includes fusion peptides comprising fragments of the cancer-related protein Her2/neu, methods of preparing such fusion peptides, virosomes comprising such fusion peptides, and uses of such fusion peptides or virosomes for the prevention, treatment or amelioration of a cancer characterized by expression or over-expression of the Her2/neu protein.
    Type: Application
    Filed: August 18, 2010
    Publication date: August 2, 2012
    Applicant: PEVION BIOTECH AG
    Inventors: Andreas Kammer, Mario Amacker, Rinaldo Zurbriggen
  • Non-Specific Immunostimulating Agents
    Publication number: 20120164181
    Abstract: The present invention includes a lipid vesicle. The invention further relates to a method of treating and/or preventing a disease or disorder involving administering such a lipid vesicle to an animal in need thereof.
    Type: Application
    Filed: February 23, 2012
    Publication date: June 28, 2012
    Inventors: Christian Moser, Andreas Kammer, Rinaldo Zurbriggen
  • NON-SPECIFIC IMMUNOSTIMULATING AGENTS
    Publication number: 20110142912
    Abstract: The present invention relates to the use of a lipid vesicle for the preparation of a medicament. The invention further relates to a method of treating and/or preventing a disease or disorder involving administering such a lipid vesicle to an animal in need thereof.
    Type: Application
    Filed: December 31, 2007
    Publication date: June 16, 2011
    Inventors: Christian Moser, Andreas Kammer, Rinaldo Zurbriggen
  • Virosomes Comprising Hemagglutinin Derived from an Influenza Virus Produced in a Cell Line, Compositions, Methods of Manufacturing, Use Thereof
    Publication number: 20110045057
    Abstract: The present invention relates to virosomes comprising hemagglutinin (HA) with improved fusion activity. Preferably, the HA comprised in said virosomes was derived from influenza virus produced in a cell line. The present invention also relates to compositions and a kit comprising the virosomes according to the invention. Further, the present invention relates to uses and methods involving said virosomes, as well as to a method for preparing same.
    Type: Application
    Filed: June 13, 2008
    Publication date: February 24, 2011
    Inventors: Rinaldo Zurbriggen, Christian Moser, Silvia Rasi, Andreas Kammer, Mario Amacker, Nicole Westerfeld
  • Novel Trans-Adjuvant System
    Publication number: 20100015214
    Abstract: The present invention relates to a novel adjuvant system that generates an efficient immune response against antigens of various origins while reducing the risk of toxic side effects attendant to the use of known adjuvants. The novel adjuvant of the present invention comprises virosomes and allows antigenic molecules to be bound to or encapsulated in a variety of delivery vehicles which are easier to prepare for virosomes.
    Type: Application
    Filed: December 15, 2006
    Publication date: January 21, 2010
    Applicant: PEVION BIOTECH LTD.
    Inventors: Rinaldo Zurbriggen, Andreas Kammer